The information provided about medicinal products is intended for informational purposes only and does not constitute an offer, advertisement, or instruction for use. Sale, delivery, and prescription of medications are not carried out through the website. For questions regarding the use of a medication, you can schedule an in-person appointment or online consultation with a relevant specialist at our clinic.
GLIALIA (ITALY)
Ingredients per tablet:
Palmitoylethanolamide 400 mg, Luteolin in co-ultramicronized form (Ultramicrocomposite PEALUT®) 40 mg, Mixture, excipients (Microcrystalline cellulose, Magnesium stearate, Vegetable Polysorbate, Polyethylene glycol/Macrogol (E1521), Sodium Croscarmellose, Povidone, Polyvinyl alcohol, Colloidal anhydrous silica, Talc, Yellow iron oxide (E172), Titanium dioxide (E171)). 225.00 mg
Palmitoylethanolamide 400 mg, Luteolin in co-ultramicronized form (Ultramicrocomposite PEALUT®) 40 mg, Mixture, excipients (Microcrystalline cellulose, Magnesium stearate, Vegetable Polysorbate, Polyethylene glycol/Macrogol (E1521), Sodium Croscarmellose, Povidone, Polyvinyl alcohol, Colloidal anhydrous silica, Talc, Yellow iron oxide (E172), Titanium dioxide (E171)). 225.00 mg
80у.е.
The drug Glialia is used for:
- consequences of ischemic cerebral circulation disorders (TIA);
- post-stroke conditions based on ischemia;
- post-traumatic CNS conditions;
- cognitive impairments;
- early-stage dementia;
- early-stage Parkinson's disease;
- inflammatory demyelinating diseases;
- motor neuron diseases.
It is recommended to take 2 tablets per day (one in the morning and one in the evening) for long cycles of 6 months, with the possibility of repeating if necessary.
Use under medical supervision.
Not recommended for use during pregnancy.
60 coated tablets of 400 mg + 40 mg.
- consequences of ischemic cerebral circulation disorders (TIA);
- post-stroke conditions based on ischemia;
- post-traumatic CNS conditions;
- cognitive impairments;
- early-stage dementia;
- early-stage Parkinson's disease;
- inflammatory demyelinating diseases;
- motor neuron diseases.
It is recommended to take 2 tablets per day (one in the morning and one in the evening) for long cycles of 6 months, with the possibility of repeating if necessary.
Use under medical supervision.
Not recommended for use during pregnancy.
60 coated tablets of 400 mg + 40 mg.
